|
Name |
Arthropsolide A
|
| Molecular Formula | C13H14O5 | |
| IUPAC Name* |
(4S,5R,6S,10S)-4,6-dihydroxy-3-methylidene-10-[(E)-prop-1-enyl]-2-oxaspiro[4.5]dec-8-ene-1,7-dione
|
|
| SMILES |
C/C=C/[C@H]1C=CC(=O)[C@H]([C@]12[C@@H](C(=C)OC2=O)O)O
|
|
| InChI |
InChI=1S/C13H14O5/c1-3-4-8-5-6-9(14)11(16)13(8)10(15)7(2)18-12(13)17/h3-6,8,10-11,15-16H,2H2,1H3/b4-3+/t8-,10+,11+,13+/m0/s1
|
|
| InChIKey |
ROOGVCKSAVTPSZ-KMSURZFUSA-N
|
|
| Synonyms |
Arthropsolide A; 135048-14-5; (4S,5R)-4beta,10beta-Dihydroxy-3-methylene-6beta-[(E)-1-propenyl]-2-oxaspiro[4.5]dec-7-ene-1,9-dione; (4S,5R,6S,10S)-4,6-dihydroxy-3-methylidene-10-[(E)-prop-1-enyl]-2-oxaspiro[4.5]dec-8-ene-1,7-dione; NSC661230; CHEMBL1982276; NSC-661230
|
|
| CAS | NA | |
| PubChem CID | 5467970 | |
| ChEMBL ID | CHEMBL1982276 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 250.25 | ALogp: | -0.1 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 83.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 18 | QED Weighted: | 0.523 |
| Caco-2 Permeability: | -4.653 | MDCK Permeability: | 0.00002280 |
| Pgp-inhibitor: | 0.022 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.058 |
| 30% Bioavailability (F30%): | 0.006 |
| Blood-Brain-Barrier Penetration (BBB): | 0.986 | Plasma Protein Binding (PPB): | 67.85% |
| Volume Distribution (VD): | 0.304 | Fu: | 41.96% |
| CYP1A2-inhibitor: | 0.058 | CYP1A2-substrate: | 0.161 |
| CYP2C19-inhibitor: | 0.03 | CYP2C19-substrate: | 0.433 |
| CYP2C9-inhibitor: | 0.022 | CYP2C9-substrate: | 0.072 |
| CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.151 |
| CYP3A4-inhibitor: | 0.031 | CYP3A4-substrate: | 0.239 |
| Clearance (CL): | 8.035 | Half-life (T1/2): | 0.617 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.075 |
| Drug-inuced Liver Injury (DILI): | 0.214 | AMES Toxicity: | 0.507 |
| Rat Oral Acute Toxicity: | 0.991 | Maximum Recommended Daily Dose: | 0.967 |
| Skin Sensitization: | 0.953 | Carcinogencity: | 0.743 |
| Eye Corrosion: | 0.803 | Eye Irritation: | 0.799 |
| Respiratory Toxicity: | 0.972 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005953 | ![]() |
0.627 | D03KXY | ![]() |
0.224 | ||
| ENC005952 | ![]() |
0.391 | D03TGJ | ![]() |
0.214 | ||
| ENC001883 | ![]() |
0.322 | D0Y7DP | ![]() |
0.205 | ||
| ENC005124 | ![]() |
0.322 | D0CL9S | ![]() |
0.205 | ||
| ENC004776 | ![]() |
0.288 | D0K7LU | ![]() |
0.198 | ||
| ENC001843 | ![]() |
0.283 | D0Z8EX | ![]() |
0.195 | ||
| ENC003396 | ![]() |
0.273 | D0R2KF | ![]() |
0.193 | ||
| ENC001995 | ![]() |
0.272 | D09PZO | ![]() |
0.190 | ||
| ENC004778 | ![]() |
0.264 | D0TS1Z | ![]() |
0.190 | ||
| ENC004777 | ![]() |
0.264 | D0D2VS | ![]() |
0.185 | ||